Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use

PHARMACOGENOMICS · Published 2026-06-03 · DOI 10.1080/14622416.2026.2686866

Free full text

Authors (1)

B. T. Baune

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Baune, B. (2026). Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use. PHARMACOGENOMICS. https://doi.org/10.1080/14622416.2026.2686866

Related articles

• How to implement pre-emptive pharmacogenetic testing in the acute hospital setting · PHARMACOGENOMICS · 2025 · Same journal
• Opportunities and challenges for the implementation of pharmacogenomics in supportive care for gastrointestinal cancer patients in Zimbabwe · PHARMACOGENOMICS · 2025 · Same journal
• ADIPOQ genotypes and haplotypes, circulating adiponectin levels and responsiveness to antihypertensive therapy in preeclampsia · PHARMACOGENOMICS · 2025 · Same journal
• UGT1A6 variants and deferiprone-induced ADRs: a complication-specific analysis in Iranian thalassemia patients · PHARMACOGENOMICS · 2025 · Same journal
• Pharmacogenomic testing for Prader-Willi syndrome: a mixed methods analysis of caregiver experiences and utilization · PHARMACOGENOMICS · 2025 · Same journal
• Pharmacogenomics of anthracycline-cyclophosphamide-taxane chemotherapy: an influence of CYP polymorphisms and BMI on breast cancer treatment outcomes · PHARMACOGENOMICS · 2025 · Same journal
• Whole exome sequencing identifies rare variants involved in PPIX-metabolizing pathway in anti-TB drug-induced hepatitis · PHARMACOGENOMICS · 2025 · Same journal
• Antiplatelet therapy in high-bleeding risk patients with acute coronary syndrome: pharmacogenomics in the era of precision medicine · PHARMACOGENOMICS · 2026 · Same journal
• Pharmacogenomics of current antiretroviral drugs · PHARMACOGENOMICS · 2026 · Same journal
• Association of ACE I/D polymorphism with blood pressure response to valsartan-hydrochlorothiazide combination therapy in hypertensive patients from Khyber Pakhtunkhwa, Pakistan · PHARMACOGENOMICS · 2026 · Same journal